PARNELL PHARMACEUT HLDGS LTD's ticker is PARNF and the CUSIP is Q73622104. A total of 19 filers reported holding PARNELL PHARMACEUT HLDGS LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $143,000 | -21.0% | 170,000 | -16.5% | 0.01% | -10.0% |
| Q1 2017 | $181,000 | +31.2% | 203,549 | +1.5% | 0.01% | +25.0% |
| Q4 2016 | $138,000 | -74.1% | 200,549 | -45.8% | 0.01% | -60.0% |
| Q3 2016 | $532,000 | -16.2% | 369,700 | -5.1% | 0.02% | -39.4% |
| Q2 2016 | $635,000 | – | 389,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 407,143 | $2,015,000 | 0.60% |
| Artal Group S.A. | 500,000 | $2,475,000 | 0.11% |
| Perceptive Advisors | 68,800 | $341,000 | 0.02% |
| Alyeska Investment Group, L.P. | 415,918 | $2,058,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 543,477 | $2,690,000 | 0.00% |
| BlackRock Group LTD | 225,291 | $1,115,000 | 0.00% |
| BlackRock Investment Management, LLC | 89,393 | $442,000 | 0.00% |
| FMR LLC | 816,051 | $4,039,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 131 | $1,000 | 0.00% |
| JPMORGAN CHASE & CO | 117,170 | $580,000 | 0.00% |